Cargando…
Radiotherapy Both Promotes and Inhibits Myeloid-Derived Suppressor Cell Function: Novel Strategies for Preventing the Tumor-Protective Effects of Radiotherapy
Cancer immunotherapies aimed at neutralizing the programmed death-1 (PD-1) immune suppressive pathway have yielded significant therapeutic efficacy in a subset of cancer patients. However, only a subset of patients responds to antibody therapy with either anti-PD-1 or anti-PD-L1 antibodies. These pa...
Autores principales: | Ostrand-Rosenberg, Suzanne, Horn, Lucas A., Ciavattone, Nicholas G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454107/ https://www.ncbi.nlm.nih.gov/pubmed/31001479 http://dx.doi.org/10.3389/fonc.2019.00215 |
Ejemplares similares
-
Myeloid-Derived Suppressor Cells: Not Only in Tumor Immunity
por: Pawelec, Graham, et al.
Publicado: (2019) -
Ubiquitinated Proteins in
Exosomes Secreted by Myeloid-Derived
Suppressor Cells
por: Burke, Meghan C., et al.
Publicado: (2014) -
The emerging role of myeloid-derived suppressor cells in radiotherapy
por: Kang, Changhee, et al.
Publicado: (2020) -
CD3xPDL1 bi-specific T cell engager (BiTE) simultaneously activates T cells and NKT cells, kills PDL1(+) tumor cells, and extends the survival of tumor-bearing humanized mice
por: Horn, Lucas A., et al.
Publicado: (2017) -
The adaptor protein TRAF3 is an immune checkpoint that inhibits myeloid-derived suppressor cell expansion
por: Zhu, Sining, et al.
Publicado: (2023)